ELI LILLY & Co is 572.1x more valuable than Trevi Therapeutics, Inc. by market capitalization ($1.093 T vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TRVI | LLY |
|---|---|---|
| Market cap | $1.91 B | $1.093 T |
| US-listed rank | #2139 | #11 |
| Revenue (latest FY) | - | $65.18B |
| Net income (latest FY) | -$42.76M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 53.0 |
| SEC filings | 524 | 989 |
ELI LILLY & Co is 572.1x more valuable than Trevi Therapeutics, Inc. by market capitalization ($1.093 T vs $1.91 B).
Full pages: Trevi Therapeutics, Inc. and ELI LILLY & Co, or browse the full rankings.